General Information of the Compound
Compound ID
CP0860158
Compound Name
(E)-5-(2-(2-Fluoroethoxy)ethoxy)-N-(4-(4-(2-methoxyphenyl)-piperazin-1-yl)but-2-en-1-yl)-1H-indole-2-carboxamide oxalic acid
    Show/Hide
Structure
Formula
C30H37FN4O8
Molecular Weight
600.644
Canonical SMILES
COc1ccccc1N1CCN(C/C=C/CNC(=O)c2cc3cc(OCCOCCF)ccc3[nH]2)CC1.O=C(O)C(=O)O
    Show/Hide
InChI
InChI=1S/C28H35FN4O4.C2H2O4/c1-35-27-7-3-2-6-26(27)33-15-13-32(14-16-33)12-5-4-11-30-28(34)25-21-22-20-23(8-9-24(22)31-25)37-19-18-36-17-10-29;3-1(4)2(5)6/h2-9,20-21,31H,10-19H2,1H3,(H,30,34);(H,3,4)(H,5,6)/b5-4+;
    Show/Hide
InChIKey
GCQAMKSJZMJKLE-FXRZFVDSSA-N
Physicochemical Property
logP
2.8052
Rotatable Bonds
13
Heavy Atom Count
43
Polar Areas
153.66
Hydrogen Bond Donor Count
4
Hydrogen Bond Acceptor Count
8
Complexity
43

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 76318472
ChEMBL ID
CHEMBL3133868
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01005, D(2) dopamine receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 120 nM
   TI
   LI
   LO
   TS
Protein ID: PT00943, D(3) dopamine receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 3.8 nM
   TI
   LI
   LO
   TS
Protein ID: PT01161, D(4) dopamine receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 360 nM
   TI
   LI
   LO
   TS